174 related articles for article (PubMed ID: 22997972)
1. Influence of four different PTH methods on the classification of chronic kidney disease patients according to the new KDIGO guideline.
Ten BE; Van Veen MC; Vervloet MG; Fischer JC; Koopman MG; Van Dam B
Clin Lab; 2012; 58(7-8):719-24. PubMed ID: 22997972
[TBL] [Abstract][Full Text] [Related]
2. Interpretation of serum PTH concentrations with different kits in dialysis patients according to the KDIGO guidelines: importance of the reference (normal) values.
Cavalier E; Delanaye P; Vranken L; Bekaert AC; Carlisi A; Chapelle JP; Souberbielle JC
Nephrol Dial Transplant; 2012 May; 27(5):1950-6. PubMed ID: 21940481
[TBL] [Abstract][Full Text] [Related]
3. Comparison of the Elecsys PTH(1-84) assay with four contemporary second generation intact PTH assays and association with other biomarkers in chronic kidney disease patients.
Tan K; Ong L; Sethi SK; Saw S
Clin Biochem; 2013 Jun; 46(9):781-6. PubMed ID: 23384535
[TBL] [Abstract][Full Text] [Related]
4. Evaluation of IDS-iSYS intact parathyroid hormone (iPTH) and comparison to Siemens Advia Centaur iPTH assay in chronic renal failure patients and in controls.
Koivula MK; Laitinen P; Risteli J
Clin Lab; 2012; 58(5-6):403-10. PubMed ID: 22783568
[TBL] [Abstract][Full Text] [Related]
5. Switching between parathormone (PTH) assays: the impact on the diagnosis of renal osteodystrophy.
Bekő G; Butz H; Berta K; Tislér A; Olajos F; Vásárhelyi B; Patócs A
Clin Chem Lab Med; 2013 Jun; 51(6):1251-6. PubMed ID: 23241601
[TBL] [Abstract][Full Text] [Related]
6. KDOQI US commentary on the 2012 KDIGO clinical practice guideline for the evaluation and management of CKD.
Inker LA; Astor BC; Fox CH; Isakova T; Lash JP; Peralta CA; Kurella Tamura M; Feldman HI
Am J Kidney Dis; 2014 May; 63(5):713-35. PubMed ID: 24647050
[TBL] [Abstract][Full Text] [Related]
7. KDOQI US Commentary on the 2017 KDIGO Clinical Practice Guideline Update for the Diagnosis, Evaluation, Prevention, and Treatment of Chronic Kidney Disease-Mineral and Bone Disorder (CKD-MBD).
Isakova T; Nickolas TL; Denburg M; Yarlagadda S; Weiner DE; Gutiérrez OM; Bansal V; Rosas SE; Nigwekar S; Yee J; Kramer H
Am J Kidney Dis; 2017 Dec; 70(6):737-751. PubMed ID: 28941764
[TBL] [Abstract][Full Text] [Related]
8. 1alpha(OH)D3 One-alpha-hydroxy-cholecalciferol--an active vitamin D analog. Clinical studies on prophylaxis and treatment of secondary hyperparathyroidism in uremic patients on chronic dialysis.
Brandi L
Dan Med Bull; 2008 Nov; 55(4):186-210. PubMed ID: 19232159
[TBL] [Abstract][Full Text] [Related]
9. KDOQI US commentary on the 2013 KDIGO Clinical Practice Guideline for Lipid Management in CKD.
Sarnak MJ; Bloom R; Muntner P; Rahman M; Saland JM; Wilson PW; Fried L
Am J Kidney Dis; 2015 Mar; 65(3):354-66. PubMed ID: 25465166
[TBL] [Abstract][Full Text] [Related]
10. Novel parathyroid hormone (1-84) assay as basis for parathyroid hormone monitoring in renal hyperparathyroidism.
Kaczirek K; Prager G; Riss P; Wunderer G; Asari R; Scheuba C; Bieglmayer C; Niederle B
Arch Surg; 2006 Feb; 141(2):129-34; discussion 134. PubMed ID: 16490888
[TBL] [Abstract][Full Text] [Related]
11. Interpretation of serum parathyroid hormone concentrations in dialysis patients: what do the KDIGO guidelines change for the clinical laboratory?
Souberbielle JC; Cavalier E; Jean G
Clin Chem Lab Med; 2010 Jun; 48(6):769-74. PubMed ID: 20298134
[TBL] [Abstract][Full Text] [Related]
12. Association between Hemodialysis Patient Outcomes and Compliance with KDOQI and KDIGO Targets for Mineral and Bone Metabolism.
Djukanović L; Dimković N; Marinković J; Djurić Ž; Knežević V; Lazarević T; Ljubenović S; Marković R; Rabrenović V
Nephron; 2016; 132(3):168-74. PubMed ID: 26914677
[TBL] [Abstract][Full Text] [Related]
13. Comparison between whole and intact parathyroid hormone assays.
Taniguchi M; Tanaka M; Hamano T; Nakanishi S; Fujii H; Kato H; Koiwa F; Ando R; Kimata N; Akiba T; Kono T; Yokoyama K; Shigematsu T; Kakuta T; Kazama JJ; Tominaga Y; Fukagawa M
Ther Apher Dial; 2011 Jun; 15 Suppl 1():42-9. PubMed ID: 21595852
[TBL] [Abstract][Full Text] [Related]
14. Adherence to mineral and bone disorder clinical practice guidelines in chronic kidney disease.
Panawong W; Chaiyakum A; Pongskul C
J Med Assoc Thai; 2011 Oct; 94(10):1175-83. PubMed ID: 22145501
[TBL] [Abstract][Full Text] [Related]
15. Establishment of reference values in a healthy population and interpretation of serum PTH concentrations in hemodialyzed patients according to the KDIGO Guidelines using the Lumipulse® G whole PTH (3rd generation) assay.
Cavalier E; Salsé M; Dupuy AM; Bargnoux AS; Watar F; Souberbielle JC; Delanaye P; Cristol JP
Clin Biochem; 2018 Apr; 54():119-122. PubMed ID: 29501417
[TBL] [Abstract][Full Text] [Related]
16. Clinical evaluation of two novel biointact PTH(1-84) assays in hemodialysis patients.
Hecking M; Kainz A; Bielesz B; Plischke M; Beilhack G; Hörl WH; Sunder-Plassmann G; Bieglmayer C
Clin Biochem; 2012 Dec; 45(18):1645-51. PubMed ID: 23217247
[TBL] [Abstract][Full Text] [Related]
17. Evaluation of a chemiluminescence immunoassay for the determination of intact parathyroid hormone using the ADVIA Centaur.
Amal L; Bergmann P
Clin Lab; 2004; 50(11-12):695-702. PubMed ID: 15575312
[TBL] [Abstract][Full Text] [Related]
18. Impact of ergocalciferol treatment of vitamin D deficiency on serum parathyroid hormone concentrations in chronic kidney disease.
Zisman AL; Hristova M; Ho LT; Sprague SM
Am J Nephrol; 2007; 27(1):36-43. PubMed ID: 17215573
[TBL] [Abstract][Full Text] [Related]
19. Variability in parathyroid hormone assays confounds clinical practice in chronic kidney disease patients.
Eddington H; Hudson JE; Oliver RL; Fraser WD; Hutchison AJ; Kalra PA
Ann Clin Biochem; 2014 Mar; 51(Pt 2):228-36. PubMed ID: 24000371
[TBL] [Abstract][Full Text] [Related]
20. Higher parathyroid hormone (PTH) concentrations with the Architect PTH assay than with the Elecsys assay in hemodialysis patients, and a simple way to standardize these two methods.
Monge M; Jean G; Bacri JL; Lemaitre V; Masy E; Joly D; Souberbielle JC
Clin Chem Lab Med; 2009; 47(3):362-6. PubMed ID: 19199835
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
